Record added: Oct. 24, 2017, 9:41 a.m.
Record updated: Oct. 5, 2020, 4:25 p.m. by The FAIRsharing Team.

Edits to 'https://fairsharing.org/FAIRsharing.ddmatg' by 'The FAIRsharing Team' at 16:25, 05 Oct 2020 (not approved):

	'user_defined_tags' has been modified:
		Before:
			Approved drug
		After:
		Added:
		Removed:
			Approved drug

	'miriam_id' has been modified:
		Before: 
		After: None

	'onto_domains' has been modified:
		Before:
			Adverse Reaction
		After:
			Adverse Reaction
			Approved drug
		Added:
			Approved drug
		Removed:

            

Edits to 'https://fairsharing.org/FAIRsharing.ddmatg' by 'The FAIRsharing Team' at 14:24, 20 Feb 2018 (approved):

	'contactName' has been modified:
		Before:
			Oliver He
		After:
			Yongqhun He
		Added:
		Removed:

            

Edits to 'https://fairsharing.org/FAIRsharing.ddmatg' by 'The FAIRsharing Team' at 13:44, 19 Feb 2018 (approved):

	'description' has been modified:
		Before: ODNAE is an extension of OAE with a focus on drug-associated neuropathy adverse events.
		After: The Ontology of Drug Neuropathy Adverse Events (ODNAE) is an extension of OAE which serves as a knowledge base comprising drug components, chemical entities of active drug ingredients, drug mechanisms, and drug-inducing neuropathy AEs. ODNAE is a platform for building a drug-induced neuropathy knowledge base and for analyzing the underlying mechanisms of drug-induced neuropathy. The ODNAE-based methods used in this study can also be extended to the representation and study of other categories of adverse events.